Celon Pharma S.A. (CLN.WA)

PLN 23.85

(-7.38%)

Total Assets Summary of Celon Pharma S.A.

Celon Pharma S.A.'s latest annual total assets in 2023 was 569.3 Million PLN , down -6.51% from previous year.
Celon Pharma S.A.'s latest quarterly total assets in 2024 Q2 was 576.33 Million PLN , up 4.38% from previous quarter.
Celon Pharma S.A. reported annual total assets of 608.93 Million PLN in 2022, down -13.89% from previous year.
Celon Pharma S.A. reported annual total assets of 707.13 Million PLN in 2021, up 0.5% from previous year.
Celon Pharma S.A. reported quarterly total assets of 552.13 Million PLN for 2024 Q1, down -3.02% from previous quarter.
Celon Pharma S.A. reported quarterly total assets of 574.88 Million PLN for 2023 Q3, down -2.76% from previous quarter.

Annual Total Assets Chart of Celon Pharma S.A. (2023 - 2012)

Historical Annual Total Assets of Celon Pharma S.A. (2023 - 2012)

Year	Total Assets	Total Assets Growth
2023	569.3 Million PLN	-6.51%
2022	608.93 Million PLN	-13.89%
2021	707.13 Million PLN	0.5%
2020	703.64 Million PLN	18.99%
2019	591.34 Million PLN	4.91%
2018	563.66 Million PLN	7.36%
2017	525.05 Million PLN	13.08%
2016	464.32 Million PLN	175.91%
2015	168.28 Million PLN	59.61%
2014	105.43 Million PLN	27.66%
2013	82.59 Million PLN	18.33%
2012	69.79 Million PLN	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	576.33 Million PLN	4.38%
2024 Q1	552.13 Million PLN	-3.02%
2023 Q3	574.88 Million PLN	-2.76%
2023 Q1	618.07 Million PLN	1.5%
2023 Q4	569.3 Million PLN	-0.97%
2023 FY	569.3 Million PLN	-6.51%
2023 Q2	591.23 Million PLN	-4.34%
2022 Q2	666.05 Million PLN	-1.51%
2022 FY	608.93 Million PLN	-13.89%
2022 Q4	608.93 Million PLN	-4.97%
2022 Q1	676.26 Million PLN	-4.37%
2022 Q3	640.75 Million PLN	-3.8%
2021 Q2	537.55 Million PLN	-4.06%
2021 Q4	707.13 Million PLN	-0.48%
2021 Q3	710.54 Million PLN	32.18%
2021 Q1	560.27 Million PLN	-20.37%
2021 FY	707.13 Million PLN	0.5%
2020 FY	703.64 Million PLN	18.99%
2020 Q4	703.64 Million PLN	3.86%
2020 Q3	677.46 Million PLN	3.5%
2020 Q2	654.57 Million PLN	14.75%
2020 Q1	570.42 Million PLN	-3.54%
2019 Q1	587.25 Million PLN	4.18%
2019 FY	591.34 Million PLN	4.91%
2019 Q4	591.34 Million PLN	1.69%
2019 Q3	581.49 Million PLN	-0.52%
2019 Q2	584.52 Million PLN	-0.46%
2018 FY	563.66 Million PLN	7.36%
2018 Q2	551.15 Million PLN	3.04%
2018 Q3	552.8 Million PLN	0.3%
2018 Q1	534.9 Million PLN	1.88%
2018 Q4	563.66 Million PLN	1.97%
2017 Q1	472.09 Million PLN	1.67%
2017 Q2	483.74 Million PLN	2.47%
2017 Q3	492.84 Million PLN	1.88%
2017 Q4	525.05 Million PLN	6.53%
2017 FY	525.05 Million PLN	13.08%
2016 FY	464.32 Million PLN	175.91%
2016 Q4	464.32 Million PLN	134.83%
2016 Q1	- PLN	-100.0%
2016 Q3	197.72 Million PLN	0.0%
2015 Q4	168.28 Million PLN	0.0%
2015 FY	168.28 Million PLN	59.61%
2014 FY	105.43 Million PLN	27.66%
2013 FY	82.59 Million PLN	18.33%
2012 FY	69.79 Million PLN	0.0%

Peer Total Assets Comparison of Celon Pharma S.A.

Name	Total Assets	Total Assets Difference